The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat.
about
Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain controlThe cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurinModulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamideCannabinoids reveal separate controls for whisking amplitude and timing in ratsThe RNA binding and transport proteins staufen and fragile X mental retardation protein are expressed by rat primary afferent neurons and localize to peripheral and central axonsLocalization of CB1 cannabinoid receptor mRNA in the brain of the chick (Gallus domesticus)The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.Recent data on cannabinoids and their pharmacological implications in neuropathic pain.Peripheral gating of pain signals by endogenous lipid mediators.Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2).Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons.Regulatory effects of anandamide on intracellular Ca(2+) concentration increase in trigeminal ganglion neuronsCB2: a cannabinoid receptor with an identity crisisModulation of pain transmission by G-protein-coupled receptors.Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABA(A) receptors.Orofacial painMultiple actions of anandamide on neonatal rat cultured sensory neurones.Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neuronsComprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal gangliaCannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons.Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain.A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons.Endovanilloids are potential activators of the trigeminovascular nocisensor complexRole of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.Characterisation of cannabinoid 1 receptor expression in the perikarya, and peripheral and spinal processes of primary sensory neurons.A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer painThe non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer painMolecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.Differential effects of the cannabinoid receptor agonist, WIN 55,212-2, on lamina I and lamina V spinal trigeminal nucleus caudalis neuronsTargeting CB2 receptors and the endocannabinoid system for the treatment of pain.The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia.The molecular interplay between endocannabinoid and neurotrophin signals in the nervous system and beyond.Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.Cannabis and Pain: A Clinical ReviewDelta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation.Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.Potentiation by WIN 55,212-2 of GABA-activated currents in rat trigeminal ganglion neurones.Plasmon-waveguide resonance studies of ligand binding to integral proteins in membrane fragments derived from bacterial and mammalian cells.N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities.Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids-Cannabinoids and Acute Stress Modulate GABA Release.
P2860
Q24568208-08C85DDF-CC4A-4AD5-A16D-B818FBD91DB4Q24676808-09B6366A-54B6-4F4C-9354-3ED369F8949BQ28248981-713786EB-5BDC-45E9-912F-B330888932CBQ28293379-8ADB5D5C-B091-4FC6-8CF9-88E967A80A1EQ28564973-57753724-CA1B-4478-900F-E2F2476CDC85Q28755529-4C7A1E1F-345A-4C28-A872-B64AE89978EFQ30733453-3C714D7D-9EF2-4ECE-87DB-245DD9A0CC1CQ33527067-6C90CB26-6385-44D3-B3ED-6681FFA7CA3FQ33608432-2C4084CF-22D3-4EF4-818C-A00C3E5BFC8DQ33992517-238FE488-F1D8-4C71-ADDC-93C9D50F57DBQ34023746-11F0727E-C8DA-48FF-BD8C-4204C1671700Q34096120-A81D1651-0ED7-45DD-8CAB-0E578263CBC5Q34098185-6D1A23BC-3F51-4228-8B5C-F630D4F4D857Q34247711-A54A92C6-0AA1-4D32-AA40-2353C9314B02Q34631608-C5E9060B-DFDD-4C5B-A1A0-48DA16AC5275Q34801865-1E7452A1-8DB4-44EB-9C05-8822C924316AQ35047032-07EB6654-58AB-4510-B614-C374A0A218B9Q35047139-FF38A75E-970D-4492-B7F1-F1A4B8CCC6F1Q35048508-96997E32-1D92-4C2E-B591-6C1F00E9A786Q35087509-A903866E-4576-4CAE-93DF-93DBDB078B25Q35600288-967D1C58-DDC0-46B0-B365-1D0E5B2665FFQ35843085-33625C1F-9D46-4866-ADBB-B189B2B38EFEQ36020582-1781CA83-2660-41D8-9E61-3AE335C70695Q36726650-4D024515-36DE-48F5-B2E7-F6C783B15701Q36990269-BEEE694D-437C-40FE-9781-BE5C3BC4C2C7Q37067266-B967EA9A-647E-40AB-8569-2D0F501CA19EQ37120771-D5B37836-AA69-4B44-BAB9-6496B74052DFQ37216017-679BE618-204B-4B9B-8258-E88F76E866BCQ37284886-863A960E-8DC4-47D1-B33D-F9068C89312AQ37371095-C4F6706F-0976-44FF-AC0E-43D64B9E8990Q37409930-FC8D5DE5-09B5-4873-9049-3097544A7624Q38185066-B455E9EF-EA02-4B06-8868-3056E6220F0EQ39135834-2900DC1C-0F8A-4913-8958-724585214A7DQ39150465-9ECF2715-FB22-484D-BD6E-F79EB4C16720Q39152632-88E15735-3BCF-47BD-8E96-52280921912BQ39727048-0B74C5BC-140B-4A24-9191-52D054825984Q41868283-269139B1-0ACB-41D4-BFA3-2F841E124FEFQ42673219-B7543341-17BE-46BA-A50C-24C6135DBA86Q42714635-94C07FE7-6D02-47FB-9FBC-ADBAD0F77A99Q42825579-E5AE0E09-D139-4DCB-9520-E06097241205
P2860
The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The neuronal distribution of c ...... rigeminal ganglion of the rat.
@ast
The neuronal distribution of c ...... rigeminal ganglion of the rat.
@en
type
label
The neuronal distribution of c ...... rigeminal ganglion of the rat.
@ast
The neuronal distribution of c ...... rigeminal ganglion of the rat.
@en
prefLabel
The neuronal distribution of c ...... rigeminal ganglion of the rat.
@ast
The neuronal distribution of c ...... rigeminal ganglion of the rat.
@en
P2093
P2860
P921
P1433
P1476
The neuronal distribution of c ...... rigeminal ganglion of the rat.
@en
P2093
C M Flores
K M Hargreaves
P2860
P304
P356
10.1016/S0306-4522(03)00333-6
P407
P577
2003-01-01T00:00:00Z